Drug Repositioning to Alleviate Systemic Inflammatory Response Syndrome Caused by Gram‐Negative Bacterial Outer Membrane Vesicles
Authors:
- 23 April 2018
- journal article
- research article
- Published by Wiley in Advanced Healthcare Materials
- Vol. 7 (13) , e1701476
Abstract
Sepsis is characterized by systemic inflammatory response syndrome (SIRS) accompanied with infection. Gram‐negative bacteria can evoke sepsis by activating the host immune system, such as the release of IL‐6 and TNF‐α, through their virulence factors. Outer membrane vesicles (OMVs), nanosized bilayered proteolipids derived from Gram‐negative bacteria, harbor various virulence factors and are shown to induce SIRS. Here, drugs are repositioned to alleviate SIRS caused by Gram‐negative bacterial OMVs. Using novel OMV‐based drug screening systems, a total of 178 commercially available drugs are primarily screened, and a total of 18 repositioned drug candidates are found to effectively block IL‐6 and TNF‐α production from OMV‐stimulated macrophages. After excluding the compounds which are previously known to intervene sepsis or which show cytotoxicity to macrophages, the compounds which show dose‐dependency in inhibiting the release of IL‐6 and TNF‐α by the OMV‐stimulated macrophages in vitro and which reduce OMV‐induced SIRS in vivo are selected. Salbutamol, a β2 adrenergic receptor agonist, is selected as a novel candidate to alleviate OMV‐induced SIRS. This study sheds light on using Gram‐negative bacterial OMVs in exploring novel candidate compounds to alleviate inflammatory diseases including sepsis.Keywords
Funding Information
- National Research Foundation of Korea (2015R1A2A1A10055961)
This publication has 41 references indexed in Scilit:
- Outer Membrane Vesicles Derived from Escherichia coli Up-Regulate Expression of Endothelial Cell Adhesion Molecules In Vitro and In VivoPLOS ONE, 2013
- Pretreatment with interleukin-6 small interfering RNA can improve the survival rate of polymicrobial cecal ligation and puncture mice by down regulating interleukin-6 productionEuropean Journal of Pharmacology, 2012
- Proteomic analysis of outer membrane vesicles derived from Pseudomonas aeruginosaProteomics, 2011
- Biological Functions and Biogenesis of Secreted Bacterial Outer Membrane VesiclesAnnual Review of Microbiology, 2010
- Naturally Produced Outer Membrane Vesicles fromPseudomonas aeruginosaElicit a Potent Innate Immune Response via Combined Sensing of Both Lipopolysaccharide and Protein ComponentsInfection and Immunity, 2010
- SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASEMediterranean Journal of Hematology and Infectious Diseases, 2010
- Outer Membrane Vesicles Derived from Escherichia coli Induce Systemic Inflammatory Response SyndromePLOS ONE, 2010
- Virulence and Immunomodulatory Roles of Bacterial Outer Membrane VesiclesMicrobiology and Molecular Biology Reviews, 2010
- Proteome analysis of outer membrane vesicles from a clinicalAcinetobacter baumanniiisolateFEMS Microbiology Letters, 2009
- Bench-to-bedside review: β-Adrenergic modulation in sepsisCritical Care, 2009